Jansson Hannes, Villard Christina, Nooijen Lynn E, Ghorbani Poya, Erdmann Joris I, Sparrelid Ernesto
Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Gastroenterology and Rheumatology Unit, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Eur J Surg Oncol. 2023 Apr;49(4):688-699. doi: 10.1016/j.ejso.2023.01.006. Epub 2023 Jan 15.
Presence of multiple hepatic lesions in intrahepatic cholangiocarcinoma (iCCA) is included in staging as a negative prognostic factor, but both prognostic value and therapeutic implications remain debated. The aim of this study was to systematically review the prognostic influence of multiple lesions on survival after resection for iCCA, with stratification for distribution and number of lesions.
Medline and Embase were systematically searched to identify records (2010-2021) reporting survival for patients undergoing primary resection for iCCA. Included were original articles reporting overall survival, with data on multiple lesions including tumour distribution (satellites/other multiple lesions) and/or number. For meta-analysis, the random effects model and inverse variance method were used. PRISMA 2020 guidelines were followed.
Thirty-one studies were included for review. For meta-analysis, nine studies reporting data on the prognostic influence of satellite lesions (2737 patients) and six studies reporting data on multiple lesions other than satellites (1589 patients) were included. Satellite lesions (hazard ratio 1.89, 95% confidence interval 1.67-2.13) and multiple lesions other than satellites (hazard ratio 2.41, 95% confidence interval 1.72-3.37) were significant negative prognostic factors. Data stratified for tumour number, while limited, indicated increased risk per additional lesion.
Satellite lesions, as well as multiple lesions other than satellites, was a negative prognostic factor in resectable iCCA. Considering the prognostic impact, both tumour distribution and number of lesions should be evaluated together with other risk factors to allow risk stratification for iCCA patients with multiple lesions, rather than precluding resection for the entire patient group.
肝内胆管癌(iCCA)中存在多个肝内病变在分期中被列为不良预后因素,但预后价值和治疗意义仍存在争议。本研究的目的是系统评价多个病变对iCCA切除术后生存的预后影响,并对病变的分布和数量进行分层。
系统检索Medline和Embase以识别报告iCCA初次切除患者生存情况的记录(2010 - 2021年)。纳入的是报告总生存情况的原始文章,包含有关多个病变的数据,包括肿瘤分布(卫星灶/其他多个病变)和/或数量。采用随机效应模型和逆方差法进行荟萃分析。遵循PRISMA 2020指南。
纳入了31项研究进行综述。荟萃分析纳入了9项报告卫星灶预后影响数据的研究(2737例患者)和6项报告卫星灶以外多个病变数据的研究(1589例患者)。卫星灶(风险比1.89,95%置信区间1.67 - 2.13)和卫星灶以外的多个病变(风险比2.41,95%置信区间1.72 - 3.37)是显著的不良预后因素。按肿瘤数量分层的数据虽然有限,但表明每增加一个病变风险增加。
卫星灶以及卫星灶以外的多个病变是可切除iCCA的不良预后因素。考虑到预后影响,应将肿瘤分布和病变数量与其他风险因素一起评估,以便对有多个病变的iCCA患者进行风险分层,而不是排除整个患者群体的手术切除。